幽门螺旋桿菌诊断市场报告：到 2030 年的趋势、预测和竞争分析

幽门螺旋桿菌诊断的趋势和预测

全球幽门螺旋桿菌诊断市场的未来看起来充满希望，医院、诊断实验室和诊所市场充满机会。预计 2024 年至 2030 年，全球幽门螺旋桿菌诊断市场将以 4.8% 的复合年增长率成长。该市场的主要驱动因素是对个人化抗生素治疗的需求不断增长、感染疾病发病率的增加、感染疾病知识的增加以及幽门螺旋桿菌感染检测的成本效益的提高。

• 按类型划分，Lucintel 预计，由于胃病发病率不断增加，需要新技术进步，试剂在预测期内仍将是最大的细分市场。
• 在这个市场的最终用途类别中，由于十二指肠溃疡、胃癌、胃炎和胃溃疡等疾病的发生率不断增加，医院可能仍然是最大的部分。
• 从地区来看，由于医疗保健基础设施的改善、FDA、NIH 和 CDC 等机构采取的行动以及新兴经济体的存在，预计北美在预测期内将出现最高的成长。

幽门螺旋桿菌诊断市场的策略性成长机会

由于人们对未经治疗的感染所带来的健康风险的认识不断提高，以及先进诊断技术的可用性不断提高，幽门螺旋桿菌诊断市场提供了巨大的成长机会。由于全球医疗保健系统优先考虑胃病的早期检测和预防，因此公司在这个不断增长的市场中扩大其产品范围具有巨大的潜力。透过利用新兴技术并扩展到新的地区，公司可以开发以前服务不足的市场并改善患者的治疗效果。

• 非侵入性诊断的扩展：专注于开发和行销非侵入性诊断（例如呼吸检测和粪便抗原测试）的公司可以利用其日益普及的机会。
• 新兴市场：亚洲、非洲和拉丁美洲的新兴市场存在着巨大的扩张机会，这些国家的医疗基础设施正在改善，胃病负担仍然很高。
• 个人化诊断和治疗：个人化医疗的发展，包括考虑遗传变异和抗菌素抗药性模式的诊断，为成长提供了新的途径。
• 与远端医疗和数位健康的整合：将诊断测试与远端医疗平台整合可以增强患者获得医疗保健的机会，特别是在偏远地区，并为诊断公司创造新的机会。
• 与医疗保健提供者的伙伴关係：与医院、诊所和製药公司的策略伙伴关係关係开发全面的诊断和治疗解决方案将推动市场成长。

幽门螺旋桿菌诊断市场的策略成长机会充足，特别是对于专注于扩大非侵入性诊断、瞄准新兴市场和整合个人化医疗的公司。与医疗保健提供者合作并利用远端医疗平台还可以扩大市场覆盖范围和患者获得治疗的机会。透过利用这些机会，公司可以将自己定位为快速成长的幽门螺旋桿菌诊断市场的领导者。

幽门螺旋桿菌诊断市场的驱动因素与挑战

幽门螺旋桿菌诊断市场受到多种因素的影响，包括人们对幽门螺旋桿菌病菌感染造成的健康风险的认识不断提高，以及对准确和非侵入性诊断工具的需求不断增加。然而，市场也面临监管障碍、测试复杂性和市场竞争等挑战。了解驱动因素和挑战对于相关人员在幽门螺旋桿菌诊断的竞争格局和发展中寻求成功至关重要。

市场驱动因素：

• 胃病患病率不断上升：与幽门螺旋桿菌病菌感染相关的胃溃疡、胃炎和胃癌发病率不断上升，推动了对诊断测试的需求。
• 转向非侵入性测试：非侵入性测试，例如呼气抗原测试和粪便抗原测试，由于其易于使用和提高患者舒适度而受到关注。
• 提高对幽门螺旋桿菌风险的认识：随着人们对幽门螺旋桿菌在胃病中的作用的认识不断增强，对早期检测和有效治疗的需求也随之增加。
• 诊断技术进步：分子诊断领域的持续技术创新，例如 PCR 和次世代定序，使幽门螺旋桿菌检测更快、更准确、侵入性更小。
• 改善医疗基础设施：新兴市场的成长机会：扩大发展中地区的医疗基础设施正在改善诊断工具的取得。

市场挑战

• 监管障碍：新诊断测试的监管核准流程复杂且耗时，减缓了创新解决方案的上市速度。
• 先进诊断的成本：与先进诊断技术相关的高成本可能会限制其采用，特别是在低收入地区和预算有限的医疗保健机构。
• 诊断准确性和假阳性：儘管取得了进步，一些诊断方法仍然存在准确性问题，可能导致假阳性和假阴性，使患者管理复杂化。

幽门螺旋桿菌诊断市场是由早期检测需求的增加、向非侵入性检测的转变以及诊断技术的进步所推动的。然而，挑战仍然存在，包括监管障碍、成本以及与其他测试方法的竞争。透过应对这些挑战并利用关键的市场驱动因素，公司可以驾驭不断变化的格局并抓住这个重要的胃肠道健康领域的成长机会。

目录

第一章执行摘要

第二章全球幽门螺旋桿菌诊断市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球幽门螺旋桿菌诊断市场趋势（2018-2023）与预测（2024-2030）
• 按类型分類的幽门螺旋桿菌诊断市场
  • 装置
  • 试剂
  • 服务
• 幽门螺旋桿菌诊断的全球市场：依技术分类
  • 免疫检测
  • POC测试
  • 分子诊断
• 全球幽门螺旋桿菌诊断市场规模（依最终用途）
  • 医院
  • 诊断实验室
  • 诊所

第四章 2018-2030年区域市场趋势及预测分析

• 按地区分類的幽门螺旋桿菌诊断市场
• 北美幽门螺旋桿菌诊断市场
• 欧洲幽门螺旋桿菌诊断市场
• 亚太地区幽门螺旋桿菌诊断市场
• 其他地区幽门螺旋桿菌诊断市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球幽门螺旋桿菌诊断市场成长机会（按类型）
  • 全球幽门螺旋桿菌诊断市场的技术成长机会
  • 全球幽门螺旋桿菌诊断市场成长机会（依最终用途）
  • 全球幽门螺旋桿菌诊断市场区域成长机会
• 全球幽门螺旋桿菌诊断市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球幽门螺旋桿菌诊断市场的产能
  • 全球幽门螺旋桿菌诊断市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Thermo Fisher Scientific
• Biohit
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories
• F. Hoffmann-La Roche
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics

Helicobacter Pylori Diagnostic Trends and Forecast

The future of the global helicobacter pylori diagnostic market looks promising with opportunities in the hospital, diagnostic laboratory, and clinic markets. The global helicobacter pylori diagnostic market is expected to grow with a CAGR of 4.8% from 2024 to 2030. The major drivers for this market are the growing need for individualized antibiotic treatment, the increase of infectious illnesses, as well as, rising knowledge of infections and enhanced cost-effectiveness of helicobacter pylori infection detection.

• Lucintel forecasts that, within the type category, reagents will remain the largest segment over the forecast period due to increasing occurrences of gastric diseases necessitating new technological advancements.
• Within this market, within the end-use category, hospitals will remain the largest segment due to the increasing incidence of conditions like duodenal ulcers, stomach cancer, gastritis, and gastric ulcers.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the creation of the healthcare infrastructure, actions taken by agencies like the FDA, NIH, and CDC, and the existence of developed economies.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Helicobacter Pylori Diagnostic Market

The Helicobacter pylori (H. pylori) diagnostic market has been experiencing significant transformations due to new technologies, improved diagnostic methods, and evolving healthcare needs. With H. pylori being a major cause of gastric ulcers and a key risk factor for gastric cancer, the demand for rapid, accurate, and non-invasive diagnostic tools continues to rise. Emerging trends in this field focus on enhancing test accuracy, speed, and patient convenience, while also reducing costs and improving accessibility to diagnostics in underserved regions.

• Advancements in Non-Invasive Testing: There is a growing adoption of non-invasive testing methods such as breath tests and stool antigen tests, which provide quicker and more comfortable alternatives to invasive biopsy procedures.
• Integration of Point-of-Care (POC) Testing: The development of portable, easy-to-use POC diagnostic devices is making H. pylori testing more accessible, especially in remote or rural areas.
• Rise of Molecular Diagnostics: Molecular techniques, such as PCR-based tests, are gaining popularity for their high sensitivity and accuracy in detecting H. pylori, particularly in complex or hard-to-diagnose cases.
• Focus on Personalized Medicine: Tailoring diagnostic tests to individual patient's needs, such as genetic susceptibility and antimicrobial resistance patterns, is becoming a key trend in H. pylori diagnostics.
• Increasing Use of Artificial Intelligence (AI): AI and machine learning algorithms are being integrated into diagnostic platforms to improve the speed and accuracy of H. pylori detection and interpretation of results.

Emerging trends in the H. pylori diagnostic market indicate a shift toward non-invasive, rapid, and highly accurate diagnostic methods, with a strong focus on accessibility and cost-effectiveness. Advances in molecular diagnostics, point-of-care devices, and AI integration will drive the next generation of H. pylori diagnostic tools. These innovations are set to significantly improve patient outcomes and expand the availability of diagnostic services globally, particularly in underserved regions.

Recent Developments in the Helicobacter Pylori Diagnostic Market

Recent developments in the Helicobacter pylori diagnostic market reflect a growing emphasis on improving the accuracy, speed, and patient experience in detecting H. pylori infections. Advances in testing technology, along with the increasing recognition of the link between H. pylori and various gastric diseases, are driving growth in the diagnostic sector. This section highlights key innovations and trends that are shaping the future of H. pylori diagnosis.

• Introduction of Advanced Breath Tests: The development of more sophisticated and accurate breath tests, such as those using isotope-labeled carbon, has improved the non-invasive detection of H. pylori infection.
• Novel Stool Antigen Tests: New, more sensitive stool antigen tests are improving diagnostic accuracy and are now being adopted for both initial diagnosis and post-treatment monitoring of H. pylori infections.
• Increased Focus on Rapid Diagnostic Kits: The market has seen the emergence of rapid diagnostic kits that provide quick results, reducing the need for laboratory-based analysis and enhancing patient convenience.
• AI-Assisted Diagnostics: Machine learning algorithms are increasingly being applied to assist in interpreting diagnostic results, improving both the accuracy and speed of diagnosing H. pylori infections.
• Collaborations with Research Institutions: Strategic collaborations between diagnostic companies and research institutions are facilitating the development of next-generation diagnostic tools, including tests that can identify antimicrobial resistance in H. pylori strains.

Recent developments in the H. pylori diagnostic market are largely driven by advancements in non-invasive testing technologies, including breath and stool antigen tests, as well as the integration of AI and machine learning into diagnostic platforms. These innovations not only enhance diagnostic accuracy and speed but also improve the patient experience. As the demand for quick and reliable H. pylori testing grows, the market is likely to see continued progress in both technology and accessibility.

Strategic Growth Opportunities for Helicobacter Pylori Diagnostic Market

The helicobacter pylori diagnostic market presents significant growth opportunities, driven by rising awareness of the health risks associated with untreated infections and the increasing availability of advanced diagnostic technologies. As global healthcare systems prioritize early detection and prevention of gastric diseases, there is substantial potential for companies to expand their offerings in this growing market. By leveraging emerging technologies and expanding into new regions, companies can tap into previously underserved markets and improve patient outcomes.

• Expansion of Non-Invasive Diagnostics: Companies focusing on the development and distribution of non-invasive diagnostic methods, such as breath tests and stool antigen tests, can capitalize on their growing popularity.
• Emerging Markets: There is a strong opportunity for expansion into emerging markets in Asia, Africa, and Latin America, where healthcare infrastructure is improving and the burden of gastric diseases remains high.
• Personalized Diagnostics and Treatment: The move toward personalized medicine, including diagnostics that take into account genetic variations and antimicrobial resistance patterns, offers new avenues for growth.
• Integration with Telemedicine and Digital Health: Integrating diagnostic tests with telemedicine platforms can enhance patient access to care, especially in remote areas, and create new business opportunities for diagnostic companies.
• Partnerships with Healthcare Providers: Strategic partnerships with hospitals, clinics, and pharmaceutical companies to develop comprehensive diagnostic and treatment solutions can boost market growth.

Strategic growth opportunities in the H. pylori diagnostic market are abundant, particularly for companies that focus on expanding non-invasive diagnostics, targeting emerging markets, and integrating personalized medicine. Collaborations with healthcare providers and leveraging telemedicine platforms will also enhance market reach and patient access to care. By capitalizing on these opportunities, companies can position themselves as leaders in the rapidly growing H. pylori diagnostic market.

Helicobacter Pylori Diagnostic Market Driver and Challenges

The helicobacter pylori diagnostic market is influenced by various factors, including the growing recognition of the health risks posed by H. pylori infections and the increasing demand for accurate and non-invasive diagnostic tools. However, the market also faces challenges, such as regulatory hurdles, the complexity of testing, and market competition. Understanding both the drivers and challenges is essential for stakeholders aiming to succeed in the competitive and evolving landscape of H. pylori diagnostics.

Market Drivers:

• Increased Prevalence of Gastric Diseases: The rising incidence of gastric ulcers, gastritis, and gastric cancer linked to H. pylori infections is driving the demand for diagnostic testing.
• Shift Toward Non-Invasive Testing: Non-invasive tests, such as breath and stool antigen tests, are gaining traction due to their ease of use and improved patient comfort.
• Growing Awareness of H. pylori Risks: As awareness about the role of H. pylori in gastric diseases increases, so does the demand for early detection and effective treatment.
• Technological Advancements in Diagnostics: Ongoing innovations in molecular diagnostics, such as PCR and next-generation sequencing, are making H. pylori detection faster, more accurate, and less invasive.
• Healthcare Infrastructure Development: Expanding healthcare infrastructure in developing regions is increasing access to diagnostic tools, creating growth opportunities in underserved markets.

Market Challenges:

• Regulatory Barriers: Regulatory approval processes for new diagnostic tests can be complex and time-consuming, slowing the time to market for innovative solutions.
• Cost of Advanced Diagnostics: High costs associated with advanced diagnostic technologies may limit adoption, particularly in low-income regions or healthcare settings with limited budgets.
• Diagnosis Accuracy and False Positives: Despite advances, some diagnostic methods still struggle with accuracy, leading to false positives or false negatives, which can complicate patient management.

The H. pylori diagnostic market is driven by increasing demand for early detection, the shift toward non-invasive testing, and advancements in diagnostic technology. However, challenges such as regulatory hurdles, cost considerations, and competition from other testing methods remain. By addressing these challenges and capitalizing on key market drivers, companies can navigate the evolving landscape and seize opportunities for growth in this important area of gastrointestinal health.

List of Helicobacter Pylori Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies helicobacter pylori diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the helicobacter pylori diagnostic companies profiled in this report include-

• Thermo Fisher Scientific
• Biohit
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories
• F. Hoffmann-La Roche
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics

Helicobacter Pylori Diagnostic by Segment

The study includes a forecast for the global helicobacter pylori diagnostic by type, technology, end use, and region.

Helicobacter Pylori Diagnostic Market by Type [Analysis by Value from 2018 to 2030]:

• Instruments
• Reagents
• Services

Helicobacter Pylori Diagnostic Market by Technology [Analysis by Value from 2018 to 2030]:

• Immunoassays
• POC
• Molecular Diagnostics

Helicobacter Pylori Diagnostic Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostics Laboratories
• Clinics

Helicobacter Pylori Diagnostic Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Helicobacter Pylori Diagnostic Market

In recent years, the Helicobacter pylori (H. pylori) diagnostic market has been growing rapidly, driven by increasing awareness of gastrointestinal problems and the rising incidence of H. pylori-related conditions globally. Diagnostic innovations, particularly non-invasive tests and molecular diagnostics, have significantly improved the ease of detection and increased the rate of identification of this bacterium. The market's expansion is also supported by regulatory approvals of new diagnostic devices and increased collaboration among industry players. Regions such as the USA, China, Germany, India, and Japan are at the forefront of these trends, focusing on improving health indicators through advanced diagnostics.

• United States: The U.S. market has seen a breakthrough in H. pylori diagnostics with the introduction of non-invasive methods, especially polymerase chain reaction (PCR)-based techniques that target specific gene sequences to detect the presence of H. pylori DNA in bronchoalveolar lavage fluid (BALF). Breath and stool antigen tests have gained popularity due to their fast turnaround times, which enhance patient satisfaction. Additionally, new trends in biomolecular diagnostic techniques have led to clearer and more accurate diagnostic criteria. Future market growth is expected to be driven by approvals for advanced diagnostic kits, as well as collaborations between diagnostic manufacturers and healthcare providers to improve screening practices.
• China: The H. pylori diagnostic market in China is growing rapidly, thanks to increasing health consciousness and improved healthcare facilities. The market also forecasts a rising demand for portable and efficient cellular infectious disease testing kits. The Chinese government supports gastrointestinal disorder prevention programs, which further boosts market growth. Companies like Nogoer are focusing on the development of rapidly marketable and functional diagnostic solutions tailored to the population's needs.
• Germany: Although competition in Germany for H. pylori diagnostic tests is intense, it has not deterred customers from making substantial investments, as the country remains a leader in adopting new diagnostic technologies. More physicians are incorporating rapid tests and advanced molecular diagnostic kits into their practices. Germany's market is highly regulated, meaning only the most reliable and rugged diagnostic tools are approved for use. High priority is placed on research into novel diagnostic methods through collaborations between universities and biopharmaceutical firms, which helps promote better detection and treatment of patients.
• India: The H. pylori diagnostic market in India is booming due to the rising incidence of gastrointestinal disorders. Growing investments in healthcare facilities are facilitating the adoption of newer technologies, such as rapid antigen tests and molecular diagnostics. These solutions must remain affordable to accommodate the diverse patient population. Additionally, government initiatives aimed at improving the understanding of H. pylori as a disease are enabling earlier diagnoses and treatments, thereby expanding the scope of the market.
• Japan: The H. pylori diagnostic market in Japan is highly competitive, with a strong focus on technology and research and development (R&D). The introduction of new technologies, such as breath tests, aims to enhance patient comfort without compromising diagnostic accuracy. Japanese manufacturers are developing next-generation diagnostic kits with more functionalities and ease of use. Collaborations with universities and research institutions play a key role in addressing the challenges of H. pylori populations as part of the broader national health strategy.

Features of the Global Helicobacter Pylori Diagnostic Market

Market Size Estimates: Helicobacter pylori diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Helicobacter pylori diagnostic market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: Helicobacter pylori diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, technology, end use, and regions for the helicobacter pylori diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the helicobacter pylori diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the helicobacter pylori diagnostic market by type (instruments, reagents, and services), technology (immunoassays, POC, and molecular diagnostics), end use (hospitals, diagnostics laboratories, and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Helicobacter Pylori Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Helicobacter Pylori Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Helicobacter Pylori Diagnostic Market by Type
  • 3.3.1: Instruments
  • 3.3.2: Reagents
  • 3.3.3: Services
• 3.4: Global Helicobacter Pylori Diagnostic Market by Technology
  • 3.4.1: Immunoassays
  • 3.4.2: POC
  • 3.4.3: Molecular Diagnostics
• 3.5: Global Helicobacter Pylori Diagnostic Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostics Laboratories
  • 3.5.3: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Helicobacter Pylori Diagnostic Market by Region
• 4.2: North American Helicobacter Pylori Diagnostic Market
  • 4.2.1: North American Market by Type: Instruments, Reagents, and Services
  • 4.2.2: North American Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.3: European Helicobacter Pylori Diagnostic Market
  • 4.3.1: European Market by Type: Instruments, Reagents, and Services
  • 4.3.2: European Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.4: APAC Helicobacter Pylori Diagnostic Market
  • 4.4.1: APAC Market by Type: Instruments, Reagents, and Services
  • 4.4.2: APAC Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.5: ROW Helicobacter Pylori Diagnostic Market
  • 4.5.1: ROW Market by Type: Instruments, Reagents, and Services
  • 4.5.2: ROW Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by End Use
  • 6.1.4: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Helicobacter Pylori Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Helicobacter Pylori Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Helicobacter Pylori Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Biohit
• 7.3: Quest Diagnostics
• 7.4: Meridian Bioscience
• 7.5: Bio-Rad Laboratories
• 7.6: Alpha Laboratories
• 7.7: F. Hoffmann-La Roche
• 7.8: Coris BioConcept
• 7.9: Certest Biotec
• 7.10: Epitope Diagnostics